Online Program

339592
Medication Therapy Management (MTM) in Pharmacy Practice


Tuesday, November 3, 2015 : 8:30 a.m. - 8:50 a.m.

Stuart Feldman, PhD, University of Georgia College of Public Health, Athens, GA
The pharmacy profession has a long history of supporting the public’s health but the connection and involvement of pharmacists within the greater public health community has evolved more recently. The pharmacist's contribution to the public health work force, health education, disease prevention and health promotion, public health advocacy, and health quality aids in achieving optimal public health outcomes.

A consensus definition adopted by the pharmacy profession in 2004, defines medication therapy management (MTM) as a service or group of services that optimize therapeutic outcomes for individual patients. These services include medication therapy reviews, pharmacotherapy consults, anticoagulation management, immunizations, health and wellness programs and many other clinical services. Pharmacists provide medication therapy management to support patients obtaining the optimum benefits from their medications by actively managing drug therapy and identifying, preventing and resolving medication-related problems.

This presentation focuses on the provision of MTM services as a public health responsibility of pharmacists.

Learning Areas:

Provision of health care to the public
Public health or related public policy

Learning Objectives:
Identify areas where pharmacist involvement in MTM provides support for the ageing population. Discuss policies at the local, state and national level that impact the provision of MTM services by pharmacists. Outline a framework to expand the public’s knowledge of the importance of taking responsibility for the management of their medications and health.

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am the Interim Department Head, University of Georgia College of Public Health, Department of Health Policy and Management and Chair of the Pharmacy Public Health Special Primary Interest Group (SPIG) of the American Public Health Association (APHA).
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.